These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 10575183)
1. Use of cefazolin for peritonitis treatment in peritoneal dialysis patients. Agraharkar M; Klevjer-Anderson P; Rubinstien E; Galen M Am J Nephrol; 1999; 19(5):555-8. PubMed ID: 10575183 [TBL] [Abstract][Full Text] [Related]
2. The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study . Yang L; Gong N; Zhou H; Jiang J Clin Nephrol; 2019 Jul; 92(1):44-51. PubMed ID: 31131821 [TBL] [Abstract][Full Text] [Related]
3. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis. Wong KM; Chan YH; Cheung CY; Chak WL; Choi KS; Leung SH; Leung J; Chau KF; Tsang DN; Li CS Am J Kidney Dis; 2001 Jul; 38(1):127-31. PubMed ID: 11431192 [TBL] [Abstract][Full Text] [Related]
4. Recurrent and relapsing peritonitis: causative organisms and response to treatment. Szeto CC; Kwan BC; Chow KM; Law MC; Pang WF; Chung KY; Leung CB; Li PK Am J Kidney Dis; 2009 Oct; 54(4):702-10. PubMed ID: 19577352 [TBL] [Abstract][Full Text] [Related]
5. Microbiological Trends and Antimicrobial Resistance in Peritoneal Dialysis-Related Peritonitis, 2005 to 2014. Zelenitsky SA; Howarth J; Lagacé-Wiens P; Sathianathan C; Ariano R; Davis C; Verrelli M Perit Dial Int; 2017; 37(2):170-176. PubMed ID: 27738087 [TBL] [Abstract][Full Text] [Related]
6. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Ghali JR; Bannister KM; Brown FG; Rosman JB; Wiggins KJ; Johnson DW; McDonald SP Perit Dial Int; 2011; 31(6):651-62. PubMed ID: 21719685 [TBL] [Abstract][Full Text] [Related]
7. Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin. Fogel MA; Nussbaum PB; Feintzeig ID; Hunt WA; Gavin JP; Kim RC Am J Kidney Dis; 1998 Sep; 32(3):401-9. PubMed ID: 9740155 [TBL] [Abstract][Full Text] [Related]
8. [Peritonitis in intermittent peritoneal dialysis: microbiological aspects and the antibiogram]. Romão Júnior JE; Fortes RM; Fadil MA; Gushi N; Vaz WS; Marcondes M; Sabbaga E Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):100-3. PubMed ID: 2616993 [TBL] [Abstract][Full Text] [Related]
9. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops. Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones. Chawla B; Agarwal P; Tandon R; Titiyal JS; Sharma N; Agarwal T; Navak N; Satpathy G Eur J Ophthalmol; 2010; 20(2):300-5. PubMed ID: 19924668 [TBL] [Abstract][Full Text] [Related]
11. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen. Goldberg L; Clemenger M; Azadian B; Brown EA Am J Kidney Dis; 2001 Jan; 37(1):49-55. PubMed ID: 11136167 [TBL] [Abstract][Full Text] [Related]
12. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Kim DK; Yoo TH; Ryu DR; Xu ZG; Kim HJ; Choi KH; Lee HY; Han DS; Kang SW Perit Dial Int; 2004; 24(5):424-32. PubMed ID: 15490981 [TBL] [Abstract][Full Text] [Related]
13. Four-year analysis of microbial aetiology and antimicrobial sensitivity patterns of peritoneal-dialysis related peritonitis in a tertiary care facility. Persy B; Ieven M Acta Clin Belg; 2013; 68(1):48-53. PubMed ID: 23627195 [TBL] [Abstract][Full Text] [Related]
14. Positive dialysate gram stain predicts outcome of empirical antibiotic therapy for peritoneal dialysis-associated peritonitis. Lee CC; Sun CY; Chang KC; Wu MS Ther Apher Dial; 2010 Apr; 14(2):201-8. PubMed ID: 20438543 [TBL] [Abstract][Full Text] [Related]
15. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients. Khairullah Q; Provenzano R; Tayeb J; Ahmad A; Balakrishnan R; Morrison L Perit Dial Int; 2002; 22(3):339-44. PubMed ID: 12227391 [TBL] [Abstract][Full Text] [Related]
16. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Zelenitsky S; Barns L; Findlay I; Alfa M; Ariano R; Fine A; Harding G Am J Kidney Dis; 2000 Nov; 36(5):1009-13. PubMed ID: 11054358 [TBL] [Abstract][Full Text] [Related]
17. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients. Ariano RE; Franczuk C; Fine A; Harding GK; Zelenitsky SA Perit Dial Int; 2002; 22(3):335-8. PubMed ID: 12227390 [TBL] [Abstract][Full Text] [Related]
18. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Krishnan M; Thodis E; Ikonomopoulos D; Vidgen E; Chu M; Bargman JM; Vas SI; Oreopoulos DG Perit Dial Int; 2002; 22(5):573-81. PubMed ID: 12455568 [TBL] [Abstract][Full Text] [Related]
19. A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients? Kan GW; Thomas MA; Heath CH Perit Dial Int; 2003; 23(5):465-8. PubMed ID: 14604199 [TBL] [Abstract][Full Text] [Related]
20. Peritoneal dialysis-related peritonitis in the years 2005-2007 among patients of the Peritoneal Dialysis Clinic of the Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University in Szczecin. Kabat-Koperska J; Gołembiewska E; Ciechanowski K Pol Arch Med Wewn; 2008 Dec; 118(12):694-9. PubMed ID: 19202946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]